A Placebo-Controlled Trial of Atomoxetine in Marijuana-Dependent Individuals with Attention Deficit Hyperactivity Disorder

被引：59
|
作者：
McRae-Clark, Aimee L. [1 ]
Carter, Rickey E. [2 ]
Killeen, Therese K. [1 ]
Carpenter, Matthew J. [1 ]
White, Kathleen G. [1 ]
Brady, Kathleen T. [1 ]
机构：
[1] Med Univ S Carolina, Dept Psychiat & Behav Sci, Charleston, SC 29425 USA
[2] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA
来源：
AMERICAN JOURNAL ON ADDICTIONS | 2010年 / 19卷 / 06期
关键词：
DEFICIT/HYPERACTIVITY DISORDER; SUBSTANCE-ABUSE; ADULT ADHD; SUBTHRESHOLD DIAGNOSES; LATE-ONSET; FOLLOW-UP; ALCOHOL; METHYLPHENIDATE; COMORBIDITY; COGNITION;
D O I：
10.1111/j.1521-0391.2010.00076.x
中图分类号：
R194 [卫生标准、卫生检查、医药管理];
学科分类号：
摘要：
This study evaluated the effects of atomoxetine on the symptoms of attention deficit hyperactivity disorder (ADHD) and marijuana use in marijuana-dependent adults. In conjunction with motivational interviewing, participants received either atomoxetine (n = 19) or matching placebo (n = 19) for 12 weeks. Participants randomized to atomoxetine had greater improvement in ADHD on the Clinical Global Impression-Improvement scale than participants treated with placebo. No treatment group differences in self-rated ADHD symptoms, overall Wender-Reimherr Adult Attention Deficit Disorder Scale scores, or marijuana use outcomes were noted. These results suggest that atomoxetine may improve some ADHD symptoms but does not reduce marijuana use in this population. (Am J Addict 2010;00:1-9).
引用
收藏
页码：481 / 489
页数：9
相关论文
共 50 条
  • [21] Atomoxetine Treatment of Attention-Deficit/Hyperactivity Disorder in Young Adults With Assessment of Functional Outcomes A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
    Durell, Todd M.
    Adler, Lenard A.
    Williams, Dave W.
    Deldar, Ahmed
    McGough, James J.
    Glaser, Paul E.
    Rubin, Richard L.
    Pigott, Teresa A.
    Sarkis, Elias H.
    Fox, Bethany K.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2013, 33 (01) : 45 - 54
  • [22] A randomized, double-blind and placebo-controlled trial of modafinil in children and adolescents with attention deficit and hyperactivity disorder
    Kahbazi, Manijeh
    Ghoreishi, Aboulfazl
    Rahiminejad, Fatemeh
    Mohammadi, Mohammad-Reza
    Kamalipour, Abbas
    Akhondzadeh, Shahin
    PSYCHIATRY RESEARCH, 2009, 168 (03) : 234 - 237
  • [23] Dasotraline in Children with Attention-Deficit/Hyperactivity Disorder: A Six-Week, Placebo-Controlled, Fixed-Dose Trial
    Findling, Robert L.
    Adler, Lenard A.
    Spencer, Thomas J.
    Goldman, Robert
    Hopkins, Seth C.
    Koblan, Kenneth S.
    Kent, Justine
    Hsu, Jay
    Loebel, Antony
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2019, 29 (02) : 80 - 89
  • [24] Zinc for Attention-Deficit/Hyperactivity Disorder: Placebo-Controlled Double-Blind Pilot Trial Alone and Combined with Amphetamine
    Arnold, L. Eugene
    DiSilvestro, Robert A.
    Bozzolo, Dawn
    Bozzolo, Hernan
    Crowl, Lindsay
    Fernandez, Soledad
    Ramadan, Yaser
    Thompson, Susan
    Mo, Xiaokui
    Abdel-Rasoul, Mahmoud
    Joseph, Elizabeth
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2011, 21 (01) : 1 - 19
  • [25] Combined methylphenidate and atomoxetine pharmacotherapy in attention deficit hyperactivity disorder
    Ozbaran, Burcu
    Kose, Sezen
    Yuzuguldu, Onur
    Atar, Burcu
    Aydin, Cahide
    WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2015, 16 (08) : 619 - 624
  • [26] ATTENTION DEFICIT HYPERACTIVITY DISORDER IN IMPRISONED INDIVIDUALS - A REVIEW
    Ghanizadeh, Ahmad
    Mohammadi, Mohammad Reza
    Akhondzadeh, Shahin
    Sanaei-Zadeh, Hossein
    PSYCHIATRIA DANUBINA, 2011, 23 (02) : 139 - 144
  • [27] Extended-Release Mixed Amphetamine Salts for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cannabis Use Disorder: A Pilot, Randomized Double-Blind, Placebo-Controlled Trial
    Levin, Frances R.
    Mariani, John J.
    Pavlicova, Martina
    Choi, C. Jean
    Basaraba, Cale
    Mahony, Amy L.
    Brooks, Daniel J.
    Brezing, Christina A.
    Naqvi, Nasir
    JOURNAL OF ATTENTION DISORDERS, 2024, 28 (11) : 1467 - 1481
  • [28] The efficacy of atomoxetine in treating adult attention deficit hyperactivity disorder (ADHD): A meta-analysis of controlled trials
    Ravishankar, Vinutha
    Chowdappa, Suresh Vedaveni
    Benegal, Vivek
    Muralidharan, Kesavan
    ASIAN JOURNAL OF PSYCHIATRY, 2016, 24 : 53 - 58
  • [29] Acetyl-L-Carnitine as an Adjunctive Therapy in the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: A Placebo-Controlled Trial
    Abbasi, Seyed-Hesameddin
    Heidari, Shahram
    Mohammadi, Mohammad-Reza
    Tabrizi, Mina
    Ghaleiha, Ali
    Akhondzadeh, Shahin
    CHILD PSYCHIATRY & HUMAN DEVELOPMENT, 2011, 42 (03) : 367 - 375
  • [30] Spotlight on Atomoxetine in Attention-Deficit Hyperactivity Disorder in Children and Adolescents
    Garnock-Jones, Karly P.
    Keating, Gillian M.
    CNS DRUGS, 2010, 24 (01) : 85 - 88
12345